Winthrop Advisory Group »

Regeneron Pharmaceuticals shares owned by Winthrop Advisory Group

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Winthrop Advisory Group from 13F filings

Historical chart of Winthrop Advisory Group investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Winthrop Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Winthrop Advisory Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $284k 295 962.49
2023-12-31 $264k 300 878.29

More positions owned by Winthrop Advisory Group

Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Etf (IWB)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Blackrock Ultra (ICSH)
SPDR Portfolio Total Stock Market ETF Prtflo S&p500 Gw (SPYG)
Apple (AAPL)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Ishares Tr Rus 1000 Grw Etf (IWF)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Extend Mkt Etf (VXF)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Schwab Strategic Tr Us Dividend Eq (SCHD)

View all positions for Winthrop Advisory Group

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Geode Capital Management
Dodge & Cox
Franklin Resources
Loomis, Sayles and
Wellington Management Company
Northern Trust
Legal & General Group
Bank of America Corporation
Amundi
Bank of New York Mellon
American Century Companies

View all funds holding Regeneron Pharmaceuticals